Clementia develops drug candidates for the treatment of bone disorders... Read more
Clementia develops drug candidates for the treatment of bone disorders... Read more
CEO
Add
News
Aug 24, 2023
MarketScreener
Clementia Pharmaceuticals, Inc.: Ipsen : Completes Acquisition of Clementia Pharmaceuticals
Dec 06, 2019
FierceBiotech
Clementia: FDA hits Ipsen's $1B drug with clinical hold over safety signal
Oct 17, 2019
Pharmafile
Clementia: Ipsen acquires Blueprint drug and moves further into ultra-rare disease
May 13, 2019
Insider Monkey
Clementia: Here's What Hedge Funds Think About Clementia Pharmaceuticals Inc. (CMTA)
Apr 22, 2019
Pharamceutical Technology
Clementia: Ipsen closes $1bn Clementia Pharmaceuticals acquisition
Mar 26, 2019
GlobalNewswire
Press Release: Clementia : MERGER ALERT - CMTA and ONCE: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
Mar 21, 2019
4-traders
Clementia: Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Clementia, Multi-Color, and GTx on Behalf of Stockholders and Encourages Investors to Contact the Firm
Mar 15, 2019
Zacks
Clementia: Are You Looking for a Top Momentum Pick? Why Clementia Pharmaceuticals (CMTA) is a Great Choice
Mar 07, 2019
FinanzNachrichten
Clementia: Clementia Pharmaceuticals Inc. Obtains Interim Order for Proposed Transaction With Ipsen S.A. and Enters Into Support and Voting Agreements With Two Additional Significant Shareholders
Mar 04, 2019
Benzinga
Clementia: MERGER ALERT - ULTI and CMTA: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
Clementia Pharmaceuticals, Inc. Competitors
1
2
3
4
5
6
7
8
9
10